Valley Health System

Paramus, New Jersey 07653

3 studies enrolling now · 5 studies all time

What they study most

Acute or Chronic Coronary Artery Disease, Lung Resection, Metastatic Breast Cancer, Non-obstructive Coronary Disease, Ovarian Cancer, Solid Cancer

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study — Starting soon
• Study of Postoperative Chest Tube Management — Completed
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling